Phase 2 Glomerulopathy Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Chinese Adults With Kidney Disease
Immunoglobulin A Nephropathy (IgAN)IC-MPGNComplement 3 Glomerulopathy (C3G)
ADARx Pharmaceuticals, Inc.30 enrolled10 locationsNCT07522099
Recruiting
Phase 2
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
C3 GlomerulopathyIdiopathic Immune Complex-Mediated Glomerulonephritis
Omeros Corporation20 enrolled6 locationsNCT06209736
Recruiting
Phase 2
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
C3 GlomerulopathyDense Deposit DiseaseMembranoproliferative Glomerulonephritis+2 more
Region Skane30 enrolled4 locationsNCT04183101